Nadia Waheed

Company: OcularTx

Job title: Chief Medical Adviser

Seminars:

Fire-Side Chat: Discussing the Journey of Gaining Approval for GA Drugs & Current Challenges In the Market 1:00 pm

Discussing the path to gain approval for complement inhibitors for GA by the FDA and the rejections from the EMA Minimizing toxic side effects and reducing retinal inflammation when delivering via intravitreal injections Debating the optimal less invasive, longer lasting administration route to reduce frequence of injections for elderly patient population Understanding how the GA…Read more

day: Conference Day Two